Form 4 for CERS CERUS CORP
Accepted 2024-03-14 00:00:00 ET · period of report 2024-03-12 · accession 0001209191-24-004846 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-14 | 2024-03-12 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | +16.7K | 494.7K | +3% | — |
| DM | 2024-03-14 | 2024-03-13+ | CERS | Benjamin Richard J | Chief Medical Off | S - Sale+OE | $2.01 | -35.1K | 477.4K | -7% | -$70.7K |
| D | 2024-03-14 | 2024-03-12 | CERS | Benjamin Richard J | Chief Medical Off | M - OptEx | — | -16.7K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-12 | M | A | 16,666 | — | 494,727 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. |
| 2 | Common | Common Stock | 2024-03-14 | S | D | 17,738 | $1.97 | 459,612 | D | — | — | (F2) Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. (F4) The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
| 3 | Common | Common Stock | 2024-03-13 | S | D | 17,377 | $2.06 | 477,350 | D | — | — | (F2) Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. (F3) The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
| 4 | Derivative | Restricted Stock Unit | 2024-03-12 | M | D | 16,666 | — | 0 | D | — · — to — | 16,666 Common Stock | (F6) Not applicable. (F1) Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. (F5) The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. |